Regression of uterine leiomyomas after treatment with gestrinone, an antiestrogen, antiprogesterone
- 1 October 1986
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 155 (4) , 761-767
- https://doi.org/10.1016/s0002-9378(86)80016-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist.BMJ, 1984
- Treatment of fibrocystic disease of the breast with gestrinone, a new trienic synthetic steroid with anti-estrogen, anti-progesterone propertiesInternational Journal of Gynecology & Obstetrics, 1984
- A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogueAmerican Journal of Obstetrics and Gynecology, 1983
- Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesteroneAmerican Journal of Obstetrics and Gynecology, 1982
- Conservative treatment of uterine leiomyoma with the antiestrogen antiprogesterone R‐2323International Journal of Gynecology & Obstetrics, 1981
- Contraceptive effectiveness of silastic: Implants containing the progestin R-2323Contraception, 1975
- Clinical evaluation of an oral progestin contraceptive, R-2323, 5mg, administered at weekly intervalsContraception, 1974
- Induction of degenerative changes in uterine myomas by high-dosage progestin therapyAmerican Journal of Obstetrics and Gynecology, 1966
- THE PROGESTERONE THERAPY OF HUMAN UTERINE LEIOMYOMASJournal of Clinical Endocrinology & Metabolism, 1949
- PROGESTERONE THERAPY IN UTERINE FIBROMYOMAJournal of Clinical Endocrinology & Metabolism, 1946